Clinical Trial Update: Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of dapagliflozin and saxagliptin added to basal-bolus insulin therapy in adults with Type 2 diabetes has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Type 2 Diabetes | Phase 4 | Status: TERMINATED